Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales: Schöffski, P, Garfield, D H, Hercbergs, A, Wolter, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856006/
https://www.ncbi.nlm.nih.gov/pubmed/20354526
http://dx.doi.org/10.1038/sj.bjc.6605628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856006/
https://www.ncbi.nlm.nih.gov/pubmed/20354526
http://dx.doi.org/10.1038/sj.bjc.6605628

Ejemplares similares